Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: Clinical characteristics, diagnosis, pathogenesis, and treatment

Seminars in Thrombosis and Hemostasis

Volumn 34, Issue 3, 2008, Pages 267-273

  Tincani, Angela ^a,c   Bazzani, Chiara ^a,c   Zingarelli, Stefania ^a,c   Lojacono, Andrea ^b,c  

^a Rheumatology and Clinical Immunology   (Italy)

^b Obstetrics and Gynecology   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Fetal loss; HELLP syndrome; Preeclampsia; Recurrent miscarriages

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROSTACYCLIN; THROMBOXANE; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL DIFFERENTIATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DELIVERY; DIABETES MELLITUS; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FETUS WASTAGE; HELLP SYNDROME; HUMAN; HYPERTENSION; IMMUNOPATHOGENESIS; LOW DRUG DOSE; MONOTHERAPY; NEWBORN CARE; OBSTETRIC CARE; OSTEOPOROSIS; PATIENT MONITORING; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RHEUMATOLOGY; SIDE EFFECT; SPONTANEOUS ABORTION; TERATOGENESIS; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; TREATMENT INDICATION; TROPHOBLAST;

ABORTION, HABITUAL; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL GROWTH RETARDATION; HELLP SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA; THROMBOSIS; TROPHOBLASTS;

EID: 50249174457     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0028-1082270     Document Type: Article

References (56)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306
2. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-365
3. Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-365
4. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-763
5. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-1311
6. Maier DB, Parke A. Subclinical autoimmunity in recurrent aborters. Fertil Steril 1989;51:280-285
7. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996;66:24-29
8. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-493
9. Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996;14:131-136
10. Branch DW, Dudley DJ, Scott JR, Silver RM. Antiphospholipid antibodies and fetal loss. N Engl J Med 1992;326:952-954
11. Branch DW, Andres R, Digre KB, et al. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989;73:541-545
12. Faden D, Tincani A, Tanzi P, et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;73:37-42
13. Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007;9:219-225
14. Asherson RA, Galarza-Maldonado C, Sanin-Blair J. The HELLP syndrome, antiphospholipid antibodies, and syndromes. Clin Rheumatol 2008;27:1-4
15. Le Thi Thuong D, Tieulié N, Costedoat N, et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005;64:273-278
16. Tsirigotis P, Mantzios G, Pappa V, et al. Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome. Rheumatol Int 2007;28(2):171-174
17. Erkan D, Tincani A, Meroni P, Lockshin M. Practice questions/answers about antiphospholipid syndrome pregnancy. Presented at: the American College of Rheumatology annual meeting; November 6-11, 2007; Boston, MA
18. Carp HJ, Shoenfeld Y. Anti-phospholipid antibodies and infertility. Clin Rev Allergy Immunol 2007;32:159-161
19. Sanmarco M, Bardin N, Camoin L, et al. Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization. Ann N Y Acad Sci 2007;1108:457-465
20. Long AA, Ginsberg JS, Brill-Edwards P, et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 1991;66:520-524
21. Petri M. Classification and epidemiology of the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld Y, eds. The Antiphospholipid Syndrome II: Autoimmune Thrombosis. Amsterdam: Elsevier; 2002:11-20
22. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-1027
23. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to b2 glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002;109:797-804
24. Goel N, Ortel T, Bali D, et al. Familial antiphospholipid antibody syndrome: criteria for disease and evidence for autosomal dominant inheritance. Arthritis Rheum 1999;42:318-327
25. Savi M, Ferraccioli GF, Neri TM, et al. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988;31:1568-1570
26. Arnett FC, Thiagarajan P, Ahn C, Reveille JD. Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. Arthritis Rheum 1999;42:268-274
27. Caliz R, Atsumi T, Kondeatis E, et al. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology 2001;40:31-36
28. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiohospholipid syndrome in naive mice with lupus monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci U S A 1991;88:3069-3073
29. Meroni PL, Riboldi P. Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 2001;13:377-382
30. Rote NS, Lyden TW, Vogt E, et al. Expression of phosphatidylserine epitopes during trophoblast membrane fusion: an alternative hypothesis for antiphospholipid antibody associated pregnancy disorders. In: Dondero E, Johnson PM, eds. Reproductive Immunology. New York: Serono Symposia Publications, Raven Press; 1993;97:281-284
31. Rand JH. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. J Autoimmun 2000;15:107-111
32. Di Simone N, Raschi E, Testoni C, et al. Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro. Ann Rheum Dis 2005;64:462-467
33. Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211-220
34. Girardi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injur)' in the antiphospholipid syndrome. J Clin Invest 2003;112:1644-1654
35. Martinez de la Torre Y, Buracchi C, Borroni EM, et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A 2007;104:2319-2324
36. Meroni PL, Di Simone N, Testoni C, et al. Antiphospholipid antibodies as cause of pregnancy loss. Lupus 2004;13:649-652
37. Venkat-Raman N, Backos M, Teoh TG, et al. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet Gynecol 2001;98:235-242
38. Sangle S, D'Cruz DP, Hughes GR. Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis 2005;64:147-148
39. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000;43:440-443
40. Blank M, Shoenfeld Y. Antiphosphatidylserine antibodies and reproductive failure. Lupus 2004;13:661-665
41. Shoenfeld Y, Carp HJ, Molina V, et al. Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol 2006;56:337-344
42. Lubbe WF, Butler WS, Palmer SJ, et al. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983;1:1361-1363
43. Coomarasamy A, Honest H, Papaioannou S, et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003;101:1319-1332
44. Cowchock FS, Reece EA, Balaban D, et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-1323
45. Rai R, Cohen H, Dave M, et al. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipids antibodies (or antiphospholipid antibodies). BMJ 1997;314:253-257
46. Kutteh WH. Antiphospholipid antibody associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584-1589
47. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized controlled trial of treatment. Obstet Gynecol 2002;100:408-413
48. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993-997
49. Tincani A, Branch W, Levy RA, et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 2003;12:524-529
50. Pauzner R, Dulitzki M, Lanevitz P, et al. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001;86:1379-1384
51. Ostensen M, Khamashta M, Lockshin M, et al. Antiinflammatory and immunosuppressive drugs and reproduction. Available at: http://arthritis- research.com/content/8/3/209. Accessed July 16, 2008
52. Ruiz-Irastorza G, Khamashta MA, Hughes GR. Heparin and osteoporosis during pregnancy: 2002 update. Lupus 2002;11:680-682
53. Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000;182:122-127
54. Petri M. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 1996;5:S16-S22
55. Sammaritano LR. Therapy insight: guidelines for selection of contraception in woman with rheumatic disease. Nat Clin Pract Rheumatol 2007;3:273-281
56. Zatti S, Biasini Rebaioli C, Lojacono A. Antiphospholipid syndrome and pregnancy. Women's Health 2006;2:873-880